Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
Corrigendum.
Complete bilateral horizontal internuclear ophthalmoplegia as a sign of multiple sclerosis relapse.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Assisted reproduction technology in multiple sclerosis: Giving birth to a new avenue of research in hormones and autoimmunity.
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Evidence linking HHV-6 with multiple sclerosis: an update.
Paraneoplastic and other autoimmune disorders of the central nervous system.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.
Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
Prevalence and clinical features of multiple sclerosis in Latin America.
Labor induction and augmentation in women with multiple sclerosis.
Quantification of gait kinematics and walking ability of people with multiple sclerosis who are new users of functional electrical stimulation.
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
Molecular mimicry in the etiology of autoimmune diseases.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Pages
« first
‹ previous
…
263
264
265
266
267
268
269
270
271
…
next ›
last »